metabolic associated fatty liver disease
Conditions
Interventions
Qi-Zhu:Qi-Zhu Formula
control group:Metformin
Sponsors
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Meets the diagnostic criteria for MAFLD (Metabolic Associated Fatty Liver Disease) according to Western medicine. 2.Meets the syndrome differentiation criteria for spleen deficiency with dampness obstruction in Traditional Chinese Medicine. 3.Aged 18-70 years with no restriction on gender. 4.Informed consent has been obtained for participation in this study.
Exclusion criteria
Exclusion criteria: 1.Individuals with comorbid autoimmune diseases medication use pregnancy or other conditions that may lead to hepatic steatosis. 2.ALT levels exceeding three times the upper limit of normal. 3.Individuals with MAFLD that has progressed to cirrhosis or hepatocellular carcinoma. 4.Pregnant women women planning pregnancy or breastfeeding women. 5.Individuals with severe allergic constitutions or those who have a known allergy to the medications used in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic indicators; | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy indicators of TCM syndrome;Biological indicators;Disease efficacy indicators;Safety metrics; | — |
Countries
China
Contacts
Public ContactDongcan
Nanjing Hospital of Traditional Chinese Medicine
Outcome results
None listed